跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NX-5
首页
药物
NX-5
NX-5
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Bifidobacterium breve NX-5 and application thereof in oxidation resistance
申请人: GUANGDONG LONGSEE MEDICAL TECH CO LTD
优先权: 2021
CN
Application of bifidobacterium breve NX-5 in preparation of uric acid reducing medicine
申请人: GUANGDONG LONGSEE MEDICAL TECH CO LTD
优先权: 2023
CN
Application of bifidobacterium breve NX-5 in preparation of fat-reducing and weight-losing products
申请人: GUANGDONG LONGSEE MEDICAL TECH CO LTD
优先权: 2023
CN
Application of high-activity Zn-based catalyst Zn (at) Nx/NC in catalytic transfer hydrogenation of 5-hydroxymethylfurfural
申请人: UNIV CHONGQING TECH & BUSINESS
优先权: 2025
CN
短双歧杆菌NX-5在制备缓解焦虑、改善睡眠药物中的应用
申请人: 广东南芯医疗科技有限公司
优先权: 2023
CN
Application of lactobacillus rhamnosus NX-2 in preparation of antidepressant drugs
申请人: GUANGDONG LONGSEE MEDICAL TECH CO LTD
优先权: 2023
CN
POLYOLEFIN, PLASTICIZER FOR ELECTRONIC MATERIAL, SUBSTRATE FOR COSMETIC PREPARATION, COSMETIC PREPARATION, AND LUBRICATING AGENT
申请人: NOF CORP
优先权: 2022
US
NOVEL LIPID TRIPEPTIDE-BASED HYDROGELATOR AND HYDROGEL
申请人: NISSAN CHEMICAL IND LTD
优先权: 2007
US
2 件公开
药物
反馈